Cboe Global Markets (CBOE) Q2 2026 earnings review
Record Top-Line Meets Aggressive Margin Expansion
Cboe delivered a blowout quarter, achieving 25% YoY net revenue growth and a 45% surge in adjusted EPS. The strategic realignment—shedding underperforming or non-core assets like Japan Equities, Cboe Canada, and Cboe Australia—is supercharging profitability. Adjusted operating margins expanded 6.7 percentage points to a staggering 70.4%. The proprietary options franchise remains an unstoppable force, and management's confidence is reflected in a raised full-year organic revenue guidance to the 'mid to high teens.'
🐂 Bull Case
Options net revenue surged 30% to $473.9M. Index options ADV spiked 32% while multi-listed ADV grew 24%. The secular shift towards short-dated (0DTE) trading continues to fuel record-breaking contract volumes.
Divesting non-core operations has instantly optimized the bottom line. Adjusted operating margin leaped to 70.4%, translating 25% revenue growth into 45% adjusted earnings growth.
🐻 Bear Case
While every other segment posted double-digit growth, the Futures business grew a mere 2% YoY to $30.6M, with net transaction and clearing fees completely flat. It is visibly lagging the broader derivatives boom.
Despite a 17% revenue jump in North American Equities due to higher industry volumes, Cboe's U.S. Equities exchange market share decelerated to 9.4% from 10.5% a year ago.
⚖️ Verdict: 🟢🟢
Bullish. The strategic pivot is working perfectly. Cboe is doubling down on its wide-moat, high-margin derivatives and data businesses while ruthlessly cutting low-return segments. The result is accelerating organic growth and supreme profitability.
Key Themes
Options Segment Dominance
The Options business continues accelerating, driving the bulk of Cboe's financial success. Net revenue hit $473.9M (up 30% YoY), fueled by a 32% surge in index options ADV and a 6% increase in revenue per contract (RPC) due to a favorable product mix. The sustained demand for 0DTE (zero days to expiration) strategies is solidifying this revenue base against broader market cyclicality.
Data Vantage Momentum
Data Vantage net revenue climbed 15% YoY to $181.6M, validating the company's focus on non-transaction recurring revenue. This performance gave management the confidence to upgrade the full-year organic growth target for this specific unit from 'low double-digit' to 'low teens'. High international uptake and new unit sales are clearly outpacing legacy pricing levers.
Macro Tailwind: Broad Industry Volumes
Cboe benefited massively from industry-wide trading exuberance. Even in segments where market share slipped—like North American Equities—net transaction and clearing fees soared 37% YoY simply because the overall pie expanded (total industry ADV rose from 18.4B to 20.2B shares). Elevated macro volatility and broad market participation are acting as powerful systemic tailwinds.
Futures Segment Stagnation
The Futures business is flashing a warning sign. Net revenue grew just 2% YoY ($30.6M vs $30.1M), and net transaction and clearing fees were completely flat. This severely lagged the 30% growth in Options and 17% growth in NA Equities, demonstrating that the VIX futures complex is failing to capture the same speculative energy seen in index options.
Market Share Leaks in Equities and Options
A concerning underlying metric contradicts the revenue beats: exchange market share is shrinking. U.S. Equities exchange market share fell to 9.4% (down from 10.5% in 25Q2). European Equities dropped to 24.4% (from 25.1%). Even the flagship Options division saw total market share dip slightly to 30.0% (from 30.2%). Cboe is losing a slice of the pie, but the pie is growing so fast that it masks the underlying competitive bleed.
Other KPIs
Accelerating dramatically. The margin expanded by 6.7 percentage points from 63.7% in 25Q2. This proves the strategic realignment—shaving off high-cost, low-return divisions—is delivering immediate, structural profitability improvements.
Up from $2.22 billion at the end of FY25. Cboe's cash generation remains formidable, funding $75.7M in quarterly dividends and $32.6M in share repurchases, while leaving roughly $536.8M in remaining buyback capacity.
Stable and impressive growth. Net revenue increased 20% YoY (18% in constant currency). Cboe Clear Europe net settlement volume rose 21% to nearly 4 billion shares, showcasing deep penetration in the international clearing space.
Guidance
Accelerating. Raised from previous guidance of 'low double-digit to mid teens'. This upgrade points to management's deep conviction in the continued volume trajectory of the Options and Data Vantage segments.
Accelerating. Increased from the previous 'low double-digit' target. Reflects sustained momentum in non-transaction revenues.
Stable. Reaffirmed overall, though practically reduced by $11 million due to the imminent sale of Cboe Australia in Q3. Shows strict expense discipline amidst explosive revenue growth.
Accelerating. Raised significantly from prior guidance of $73 - $83 million. The company is actively reinvesting some of its newfound margin expansion back into technology or facility infrastructure.
Key Questions
Market Share Leakage
Despite record revenues, U.S. Equities and Options market shares have slightly eroded YoY. How much of this is deliberate revenue-capture optimization vs. genuine competitive pressure from other exchanges?
Capital Expenditure Surge
The full-year CapEx guidance was suddenly bumped up by $25 million at the midpoint. What specific infrastructure, AI deployments, or platform builds are driving this late-year spend increase?
Futures Segment Action Plan
The Futures business posted only 2% revenue growth and flat transaction fees in an otherwise booming market. Is this structural to the VIX complex in the current macro environment, or does management plan new product introductions to revive growth here?
M&A vs. Buybacks Post-Divestitures
With the imminent cash infusion from the Canada and Australia sales, combined with over $2.3B in adjusted cash, does the company plan to aggressively execute the $536M buyback authorization, or are there new M&A targets in sight?